Abstract

Indomethacin 1% Topical Gel

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2022 - Volume 26, Number 4

Page(s): 325-326

Download in electronic PDF format for $75

Abstract

A formulation for preparing Indomethacin 1% Topical Gel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2022 Pg. 325-326	Indomethacin 1% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Mar/Apr 2004 Pg. 101-105	Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Nov/Dec 1999 Pg. 496-500	Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Author(s): Goodwin Donald A, Fuhram L Clifton
Nov/Dec 2008 Pg. 543	Indomethacin 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 541	Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 146-155	In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
May/Jun 2004 Pg. 206-209	Basics of Compounding for Cold Sores or Fever Blisters Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 458	Indomethacin 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
May/Jun 2016 Pg. 230	Indomethacin Gel Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 55	Diclofenac Sodium 1%-15% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 72	Piroxicam 1% Soft-Patch Topical Gel Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 155-158	Utilization of Compounded Medications in an Oral Medicine Practice Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel